ClearPoint Neuro announces FDA Clearance and first-in-human cases using 2.2 Software with integrated Maestro Brain Modeling, and publication in NeuroImage.
SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. CLPT (the "Company"), a global device, cell, and gene therapy-enabling company…
SOLANA BEACH, Calif., Feb. 21, 2024 ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced FDA.
ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) and UFP Technologies (NASDAQ:UFPT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Risk & Volatility ClearPoint Neuro has a […]